Difference between revisions of "Journal Club"
| Line 6: | Line 6: | ||
!scope="col" style="padding:.4em" | Presenter | !scope="col" style="padding:.4em" | Presenter | ||
!scope="col" style="padding:.4em" | Paper title | !scope="col" style="padding:.4em" | Paper title | ||
| + | |- | ||
| + | |style="padding:.4em;" rowspan=2|2013/08/12 | ||
| + | |style="padding:.4em;"|2014-13 | ||
| + | |style="padding:.4em;"|JE Shim | ||
| + | |style="padding:.4em;text-align:left"| | ||
| + | [http://www.ncbi.nlm.nih.gov/pubmed/?term=24952901 Assessing the clinical utility of cancer genomic and proteomic data across tumor types.] | ||
| + | |- | ||
| + | |style="padding:.4em;"|2014-12 | ||
| + | |style="padding:.4em;"|HS Shim | ||
| + | |style="padding:.4em;text-align:left"| | ||
| + | [http://www.ncbi.nlm.nih.gov/pubmed/?term=24132290 Mutational landscape and significance across 12 major cancer types.] | ||
|- | |- | ||
|style="padding:.4em;" rowspan=2|2013/08/12 | |style="padding:.4em;" rowspan=2|2013/08/12 | ||
Revision as of 16:30, 18 July 2014
| Date | Paper index |
Presenter | Paper title |
|---|---|---|---|
| 2013/08/12 | 2014-13 | JE Shim |
Assessing the clinical utility of cancer genomic and proteomic data across tumor types. |
| 2014-12 | HS Shim |
Mutational landscape and significance across 12 major cancer types. | |
| 2013/08/12 | 2014-11 | HS Shim | |
| 2014-10 | HJ Kim |
Discovery and saturation analysis of cancer genes across 21 tumour types. | |
| 2013/08/05 | 2014-9 | CY Kim |
Comprehensive identification of mutational cancer driver genes across 12 tumor types. |
| 2014-8 | JE Shim |
IntOGen-mutations identifies cancer drivers across tumor types. | |
| 2013/07/29 | 2014-7 | CY Kim |
Computational approaches to identify functional genetic variants in cancer genomes. |
| 2014-6 | AR Cho |
Mutational heterogeneity in cancer and the search for new cancer-associated genes. | |
| 2013/07/22 | 2014-5 | AR Cho | |
| 2014-4 | AR Cho | ||
| 2014-3 | AR Cho | ||
| 2013/07/15 | 2014-2 | HJ Han | |
| 2014-1 | HJ Han |
An atlas of active enhancers across human cell types and tissues. |
2012
2011
2010